Overview
| Gender | Female |
|---|---|
| olga.greengard@mssm.edu |
E-mail: olga.greengard@mssm.edu
Tel: (212) 241-6932
Mailing Address
One Gustave L. Levy Place, Box 1198, New York, NY 10029

| Gender | Female |
|---|---|
| olga.greengard@mssm.edu |
E-mail: olga.greengard@mssm.edu
Tel: (212) 241-6932
Mailing Address
One Gustave L. Levy Place, Box 1198, New York, NY 10029
Porotto M, Murrell M, Greengard O, Moscona A. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion. J Virol. 2003 Mar; 77(6): 3647-3654.
Porotto M, Greengard O, Poltoratskaia N. A Human parainfluenza virus type 3 HN-receptor interaction: the effect of 4-GU-DANA on a neuraminidase-deficient variant. J Virol 2001; 75: 7481-7488.
Murrell M, Greengard O, Porotto M, Poltoratskaia N. A single amino acid alteration in the human parainfluenza virus type 3 HN confers resistance to both binding inhibition and neuramindiase inhibition by the antiviral agent 4-GU-DANA (Zanamivir). J Virol 2001; 75: 6310-6320.
Horga MA, Gusella GL, Greengard O, Poltoratskaia N, Porotto M, Moscona A. Mechanism of interference mediated by human parainfluenza virus type 3 infection. J Virol 2000 Dec; 74(24): 11792-11799.
Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona A. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J Virol. 2000 Dec; 74(23): 11108-11114.
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.